|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 2. Synergistic effects of sor-1 and
sop-2. (A-F) An earlier onset of ectopic expression of
egl-5 in sop-2; sor-1 mutants. Lack of expression of
egl-5::gfp in the head region in a `pretzel' stage embryo (arrow) in
sor-1 (A,B) and sop-2 (C,D) mutants. Ectopic
expression of egl-5::gfp in the head region in a `pretzel' stage
sop-2; sor-1(RNAi) embryo (E,F) (arrow). egl-5 is
expressed in the tail region in all mutant embryos. Nomarski images (A,C,E);
Fluorescence images (B,D,F). (G) Expression of egl-5::gfp in
the tail of a sor-1(RNAi) mutant (bracket). (H) Expression of
egl-5::gfp in the tail of a sop-2 mutant (bracket).
(I) Dramatically expanded expression domain of egl-5::gfp in
the tail of a sop-2; sor-1(RNAi) mutant (bracket). (J) Ectopic
expression of egl-5::gfp in the middle body region in a sop-2;
sor-1(RNAi) mutant (marked with a bar). Irregular fluorescence particles
are gut autofluorescence.
|
